Skip to main content

Table 2 Unique mutated genes in each treatment group

From: Detection of genes mutations in cerebrospinal fluid circulating tumor DNA from neoplastic meningitis patients using next generation sequencing

Mutated genes IC and ST (30 samples) IC without ST (11 samples) ST without IC (12 samples) Neither IC nor ST
(9 samples)
ERBB3 5.26% WT WT WT
FGFR3 5.26% WT WT WT
FGFR4 5.26% WT WT WT
GAS6 5.26% WT WT WT
GNA11 5.26% WT WT WT
KNSTRN 5.26% WT WT WT
MED12 5.26% WT WT WT
MTOR 5.26% WT WT WT
MYCN 5.26% WT WT WT
NFE2L2 5.26% WT WT WT
TIAF1 5.26% WT WT WT
AKT1 10.53% WT WT WT
FBXW7 10.53% WT WT WT
HRAS 10.53% WT WT WT
ABL1 15.79% WT WT WT
BAP1 WT 12.50% WT WT
MAPK1 WT 12.50% WT WT
SF3B1 WT 12.50% WT WT
PIK3R1 WT 25.00% WT WT
CSNK2A1 WT WT 10.00% WT
IL6 WT WT 10.00% WT
MET WT WT 10.00% WT
SMAD4 WT WT 10.00% WT
APEX1 WT WT WT 11.11%
BCL9 WT WT WT 11.11%
  1. Abbreviations: IC, intrathecal chemotherapy; ST, systemic therapy; WT, wide type